Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

How antiviral pill molnupiravir shot ahead in the COVID drug hunt

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout


Updates & Corrections

  • Clarification 09 October 2021: This story was updated to clarify that the two Indian drugmakers testing a generic version of molnupiravir did so independently of Merck, and to add comments from Merck indicating that moderate cases of COVID-19 in India are defined as being more severe than those in the United States.


  1. Beigel, J. H. et al. N. Engl. J. Med. 383, 1813-1826 (2020).

    Google Scholar 

  2. Sheahan, T. P. et al. Sci. Transl. Med. 12, eabb5883 (2020).

    Google Scholar 

  3. Cox, R. M. et al. Nature Microbiol. 6, 11-18 (2021).

    Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links